Recent developments in synthetic biology are described and characterized as moving the era of biotechnology into platform technologies. Platform technologies enable rapid and diffuse innovations and simultaneous product development in diffuse markets, often targeting sectors of the economy that have traditionally been thought to have little relationship to one another. In the case of synthetic biology, pharmaceutical and biofuel product development are occurring interactively. But the regulatory and ethical issues associated with these two applications share very little overlap. As such, (...) there is some risk that focus on traditional medical applications, for which the ethical expertise is highly developed, will overshadow the ethical issues that arise in connection with land use and its attendant socioeconomic consequences, especially in the developing world. The 2010 report of the Presidential Commission for the Study of Bioethics exhibits this tendency. (shrink)

Artifacts are objects intentionally made to serve a given purpose; natural objects come into being without human intervention. I shall argue that this difference does not signal any ontological deficiency in artifacts qua artifacts. After sketching my view of artifacts as ordinary objects, I’ll argue that ways of demarcating genuine substances do not draw a line with artifacts on one side and natural objects on the other. Finally, I’ll suggest that philosophers have downgraded artifacts because they think of metaphysics as (...) resting on a distinction between what is “mind­independent” and what is “mind­ dependent.” I’ll challenge the use of any such distinction as a foundation for metaphysics. (shrink)